Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein.

Yang Q, Deng X, Lu B, Cameron M, Fearns C, Patricelli MP, Yates JR 3rd, Gray NS, Lee JD.

Cancer Cell. 2010 Sep 14;18(3):258-67. doi: 10.1016/j.ccr.2010.08.008. Erratum in: Cancer Cell. 2010 Oct 19;18(4):396.

2.

Promyelocytic leukemia gene functions and roles in tumorigenesis.

Imani-Saber Z, Ghafouri-Fard S.

Asian Pac J Cancer Prev. 2014;15(19):8021-8. Review.

3.

[Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].

Fuchs O, Provazníková D, Peslová G.

Cas Lek Cesk. 2005;144(2):90-4. Review. Czech.

PMID:
15807293
4.

PML nuclear bodies and their spatial relationships in the mammalian cell nucleus.

Batty E, Jensen K, Freemont P.

Front Biosci (Landmark Ed). 2009 Jan 1;14:1182-96. Review.

PMID:
19273124
5.

Regulation of apoptosis by PML and the PML-NBs.

Bernardi R, Papa A, Pandolfi PP.

Oncogene. 2008 Oct 20;27(48):6299-312. doi: 10.1038/onc.2008.305. Review.

PMID:
18931695
6.

The promyelocytic leukemia nuclear body: sites of activity?

Eskiw CH, Bazett-Jones DP.

Biochem Cell Biol. 2002;80(3):301-10. Review.

PMID:
12123283

Supplemental Content

Support Center